BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 34124809)

  • 1. SMARCA2-NR4A3 is a novel fusion gene of extraskeletal myxoid chondrosarcoma identified by RNA next-generation sequencing.
    Wei S; Pei J; von Mehren M; Abraham JA; Patchefsky AS; Cooper HS
    Genes Chromosomes Cancer; 2021 Oct; 60(10):709-712. PubMed ID: 34124809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extraskeletal myxoid chondrosarcoma with a t(9;16)(q22;p11.2) resulting in a NR4A3-FUS fusion.
    Broehm CJ; Wu J; Gullapalli RR; Bocklage T
    Cancer Genet; 2014 Jun; 207(6):276-80. PubMed ID: 25130955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extraskeletal myxoid chondrosarcoma with non-EWSR1-NR4A3 variant fusions correlate with rhabdoid phenotype and high-grade morphology.
    Agaram NP; Zhang L; Sung YS; Singer S; Antonescu CR
    Hum Pathol; 2014 May; 45(5):1084-91. PubMed ID: 24746215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HSPA8 as a novel fusion partner of NR4A3 in extraskeletal myxoid chondrosarcoma.
    Urbini M; Astolfi A; Pantaleo MA; Serravalle S; Dei Tos AP; Picci P; Indio V; Sbaraglia M; Benini S; Righi A; Gambarotti M; Gronchi A; Colombo C; Dagrada GP; Pilotti S; Maestro R; Polano M; Saponara M; Tarantino G; Pession A; Biasco G; Casali PG; Stacchiotti S
    Genes Chromosomes Cancer; 2017 Jul; 56(7):582-586. PubMed ID: 28383167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NR4A3 fusion proteins trigger an axon guidance switch that marks the difference between EWSR1 and TAF15 translocated extraskeletal myxoid chondrosarcomas.
    Brenca M; Stacchiotti S; Fassetta K; Sbaraglia M; Janjusevic M; Racanelli D; Polano M; Rossi S; Brich S; Dagrada GP; Collini P; Colombo C; Gronchi A; Astolfi A; Indio V; Pantaleo MA; Picci P; Casali PG; Dei Tos AP; Pilotti S; Maestro R
    J Pathol; 2019 Sep; 249(1):90-101. PubMed ID: 31020999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis of extraskeletal myxoid chondrosarcoma in the thigh using EWSR1-NR4A3 gene fusion: a case report.
    Kobayashi H; Kikuta K; Sekita T; Susa M; Nishimoto K; Sasaki A; Kameyama K; Sugita S; Hasegawa T; Nakamura M; Matsumoto M; Morioka H
    J Med Case Rep; 2016 Nov; 10(1):321. PubMed ID: 27832806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel fusion variant LSM14A::NR4A3 in extraskeletal myxoid chondrosarcoma.
    Ngo C; Verret B; Vibert J; Cotteret S; Levy A; Pechoux CL; Haddag-Miliani L; Honore C; Faron M; Quinquis F; Cesne AL; Scoazec JY; Pierron G
    Genes Chromosomes Cancer; 2023 Jan; 62(1):52-56. PubMed ID: 35932215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extraskeletal myxoid chondrosarcoma: A study of 17 cases focusing on the diagnostic utility of INSM1 expression and presenting rare morphological variants associated with non-EWSR1::NR4A3 fusions.
    Lenz J; Klubíčková N; Ptáková N; Hájková V; Grossmann P; Šteiner P; Kinkor Z; Švajdler M; Michal M; Konečná P; Macháčová D; Hurník P; Tichý M; Tichý F; Kyllar M; Fiala L; Kavka M; Michal M
    Hum Pathol; 2023 Apr; 134():19-29. PubMed ID: 36563884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Next generation sequencing of extraskeletal myxoid chondrosarcoma.
    Davis EJ; Wu YM; Robinson D; Schuetze SM; Baker LH; Athanikar J; Cao X; Kunju LP; Chinnaiyan AM; Chugh R
    Oncotarget; 2017 Mar; 8(13):21770-21777. PubMed ID: 28423517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extraskeletal Myxoid Chondrosarcomas: The Uncommon Clinicopathologic Manifestations and Significance of TAF15::NR4A3 Fusion.
    Huang SC; Lee JC; Hsu YC; Tsai JW; Kao YC; Hsieh TH; Chang YM; Chang KC; Wu PS; Chen PC; Chen CH; Chang CD; Lee PH; Tai HC; Liu TT; Wen MC; Li WS; Yu SC; Wang JC; Huang HY
    Mod Pathol; 2023 Jul; 36(7):100161. PubMed ID: 36948401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intra-articular Extraskeletal EWSR1-Negative NR4A3-Positive Myxoid Chondrosarcoma: A Case Report.
    Lal DN; El-Zammar O; Naous R; Damron TA
    JBJS Case Connect; 2020; 10(2):e0614. PubMed ID: 32649120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluorescence in situ hybridization analysis of extraskeletal myxoid chondrosarcomas using EWSR1 and NR4A3 probes.
    Noguchi H; Mitsuhashi T; Seki K; Tochigi N; Tsuji M; Shimoda T; Hasegawa T
    Hum Pathol; 2010 Mar; 41(3):336-42. PubMed ID: 19775727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic utility of molecular investigation in extraskeletal myxoid chondrosarcoma.
    Benini S; Cocchi S; Gamberi G; Magagnoli G; Vogel D; Ghinelli C; Righi A; Picci P; Alberghini M; Gambarotti M
    J Mol Diagn; 2014 May; 16(3):314-23. PubMed ID: 24508382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of an Actionable Mutation of KIT in a Case of Extraskeletal Myxoid Chondrosarcoma.
    Urbini M; Indio V; Astolfi A; Tarantino G; Renne SL; Pilotti S; Dei Tos AP; Maestro R; Collini P; Nannini M; Saponara M; Murrone L; Dagrada GP; Colombo C; Gronchi A; Pession A; Casali PG; Stacchiotti S; Pantaleo MA
    Int J Mol Sci; 2018 Jun; 19(7):. PubMed ID: 29937513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fine-needle aspiration features of extraskeletal myxoid chondrosarcoma: A study of cytological and molecular features.
    Santos F; Martins C; Lemos MM
    Diagn Cytopathol; 2018 Nov; 46(11):950-957. PubMed ID: 30353688
    [